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Abstract
Background: Cardiovascular magnetic resonance imaging (CMR) is valuable for the investigation and management
of pulmonary artery hypertension (PAH), but the direct measurement of pulmonary hemodynamics by right heart
catheterization is still necessary. CMR-guided right heart catheterization (CMR-RHC) combines the benefits of CMR
and invasive cardiac catheterization, but its feasibility in patients with acquired PAH has not been established. The
aims of this study are to: (1) demonstrate the feasibility of CMR-RHC in patients being assessed for PAH in a
conventional diagnostic CMR scanner room; (2) determine the predictors of (i) procedure duration, and (ii) procedural
failure or technical difficulty as determined by the adjunctive need for a guidewire.
Methods: Fifty patients investigated for suspected or known PH underwent CMR-RHC. Durations of separate procedural
components were recorded, including time taken to pass the catheter from the femoral vein to a stable wedge position
(procedure time) and total time the patient spent in the CMR department (department time). Associations between
procedural failure/guidewire usage and hemodynamic/CMR measures were assessed using logistic regression.
Relationships between procedure times and hemodynamic/CMR measures were evaluated using Spearman’s
correlation coefficient.
Results: A full CMR-RHC study was successfully completed in 47 (94%) patients. CMR-conditional guidewires were used
in 6 (12%) patients. Metrics associated with guidewire use/procedural failure were higher mean pulmonary artery (PA)
pressures (mPAP: OR = 1.125, p = 0.018), right heart dilatation (right ventricular (RV) end-systolic volume (RVESV): OR =
1.028, p = 0.018), RV hypertrophy (OR = 1.050, p = 0.0067) and RV ejection fraction (EF) (OR = 0.914, p = 0.014). Median
catheter and department times were 3.6 (2.0–7.7) minutes and 60.0 (54.0–68.5) minutes, respectively. All procedure
times became significantly shorter with increasing procedural experience (p < 0.05). Catheterization time was also
associated with PH severity (RV systolic pressure: rho = 0.46, p = 0.0013) and increasing RV end-systolic volume (RVESV:
rho = 0.41, p = 0.0043), hypertrophy (rho = 0.43, p = 0.0025) and dysfunction (RVEF: rho = − 0.32, p = 0.031).
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Conclusions: This study demonstrates that CMR-RHC using standard technology can be incorporated into routine
clinical practice for the investigation of PAH. Procedural failure was rare but more likely in patients with severe PAH.
Procedure time is clinically acceptable and increases with worsening PAH severity.
Keywords: Cardiovascular magnetic resonance imaging, Guidewire, Interventional cardiovascular MR catheterization,
Pulmonary hypertension, Right heart catheterization
Background
Cardiovascular magnetic resonance (CMR) is a valuable
imaging technique for the investigation and management
of patients with pulmonary artery (PA) hypertension
(PAH). It provides highly accurate measurements of right
ventricular (RV) size, systolic function and mass, all of
which are prognostic [1, 2]. However, invasive catheter-
derived measurement of pulmonary artery pressure and
calculation of pulmonary vascular resistance (PVR) are
still necessary for optimum management of PAH.
One way of combining the benefits of CMR with
catheter-derived pressure measurement is CMR-
guided right heart catheterization (CMR-RHC). This
was first demonstrated in humans over 15 years ago by
Razavi et al., and has been replicated in several centres
worldwide [3–7]. This technique has several advan-
tages over conventional cardiac catheterization includ-
ing: improved soft tissue visualization, reduced
exposure to ionizing radiation and reference standard
evaluation of physiology. Nevertheless, CMR-RHC still
has not entered mainstream clinical practice. One
possible reason was that early studies were performed
in hybrid CMR/X-ray fluoroscopic suites and often
used both imaging modalities [6]. This is a barrier to
adoption due to the high cost and space requirements
of such suites. However, more recent studies have
shown that right heart catheterization is possible using
CMR alone in most patients [5, 7]. Thus, it is now
possible to incorporate CMR-RHC into routine clin-
ical practice in a conventional CMR suite.
Therefore, we set up a clinical CMR-RHC service at
one of the United Kingdom national PAH centres. The
aims of this study are: (1) to demonstrate the feasibility
of CMR-RHC in an unselected population of patients
being assessed for suspected or known PAH in a con-
ventional diagnostic CMR scanner room, and (2) to de-
termine the predictors of (i) procedure duration, and (ii)
procedural failure or technical difficulty as determined
by the adjunctive need for a guidewire.
Methods
Patient population
CMR-guided RHC was approved by the Royal Free
London NHS Foundation Trust New Interventional
Procedures Committee in November 2017. Consecutive
patients referred for RHC at the National PH Service at
the Royal Free London NHS Foundation Trust between
November 2017 and October 2018 and who were avail-
able to attend within the timeframe of newly designated
CMR-RHC sessions at our institution were offered to
undergo CMR-RHC. The clinical indication for CMR-
RHC was the same as that for conventional X-ray fluor-
oscopy-guided RHC, specifically the investigation of
suspected or known PH. In particular, patients with
scleroderma were referred for CMR-RHC either for the
investigation of symptomatic dyspnea and/or using the
DETECT algorithm, a systematic clinical screening
program used for the evidence-based detection of PAH
in this condition [8]. Exclusion criteria for CMR-RHC
were arrhythmia, patients requiring an additional X-ray
fluoroscopy-guided procedure (including coronary angi-
ography or conventional pulmonary angiography), preg-
nancy and contraindications to CMR. All ethics were
approved by the UCL/UCLH Joint Committees on the
Ethics of Human Research Committee, and all partici-
pants provided written informed consent.
CMR-RHC suite set-up
All procedures were performed in a suite equipped with
a 1.5 T CMR scanner (Magnetom Aera, Siemens
Healthcare, Erlangen, Germany). A 40-in. CMR-com-
patible monitor (NordicNeuroLab AS, Bergen, Norway)
was used to mirror the scanner display for in-room
catheter visualization. A CMR-compatible blood pres-
sure monitor (Expression MR400 or Expression IP5,
Invivo International, Philips Healthcare, Best, The
Netherlands) was used to measure invasive pressures
with the transducers attached to a CMR-compatible
drip stand (Fig. 1). Patients receiving continuous paren-
teral prostanoid therapy had their infusion adminis-
tered using a volumetric infusion pump (Infusomat
Space pump, B. Braun Medical Ltd., Sheffield, United
Kingdom) placed inside a unit with shielded aluminium
housing (SpaceStation MRI, B. Braun Medical Ltd.,
Sheffield, United Kingdom).
The staff present for the procedure included an inter-
ventional cardiologist, imaging cardiologist, CMR radi-
ographer, cardiac physiologist and a second operator in
the scanner room for patient nursing and to assist the
interventional operator when required.
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Patient preparation
Patients initially lay on the scanner table to have surface
vector-cardiogram (VCG) electrodes attached and a
phased array body coil positioned. The scanner table
was then undocked and transferred to the preparation
area just outside the scanner room door (Additional file 1:
Video S1).
Patients undergoing CMR-RHC were offered the op-
tion of mild sedation using intravenous benzodiazepines
prior to venous sheath insertion. Vascular access was ob-
tained under local anaesthetic using either manual pal-
pation or under ultrasound guidance (Additional file 1:
Video S2). The right femoral vein was chosen as the pre-
ferred route of access due to our conventional cardiac
catheterization laboratory standard operating proce-
dures, with right internal jugular access used in cases in
which femoral venous access was not feasible. In order
to maintain sterility of the operating field, the sterile
drape was folded over onto the patient firstly from the
operator side and subsequently from the opposite side of
the table (Additional file 1: Video S3). At this time, the
side of the scanner and bore closest to the operator were
also draped (Fig. 1). The patient was then transferred
back into the CMR scanner room and the table was
docked (Additional file 1: Video S4). A non-invasive
blood pressure cuff (set to automatically measure at 5-
min intervals) and a peripheral oxygen saturation finger
probe were attached to the patient. The patient is then
positioned inside the scanner bore, following which the
drapes are unfolded whilst maintaining sterility.
The catheter operator used the patient’s headphones,
allowing communication with the scanner operator. The
patient used standard CMR ear defenders and had an
alarm to activate if they wished to speak to the team
during the procedure in addition to regularly being ver-
bally checked upon by a staff member in the scanner
room.
CMR-guided right heart catheterization
Preliminary imaging
After conventional localizers, an interactive real-time se-
quence (that was subsequently also used for catheter
visualization) was used to plan three specific reference
views. These were the bicaval view, the RV long axis
(RVLA) view and the main PA bifurcation view (Fig. 2).
Catheter visualization and guidance
A 6 French 110-cm single lumen balloon wedge-pressure
end-hole catheter (Arrow, Teleflex, Buckinghamshire,
United Kingdom) was used for all catheterizations. The
balloon was filled with air during catheterization, allowing
the catheter tip to be visualized as a signal void (Fig. 3).
The catheter was advanced from the groin through the
right heart, pulmonary artery and finally to the wedge pos-
ition under CMR visualization. The interactive real-time
sequence that was used allowed the catheter to be
‘tracked’ by switching between the previously stored refer-
ence views with real-time adjustments performed by the
imaging cardiologist (Additional file 2: Video S5). The
interactive real-time sequence parameters typically used
were those as supplied by the manufacturer: TR/TE 2.4
ms/0.98ms; flip angle 50o; bandwidth 1002Hz/pixel; FOV
320 × 320 mm; matrix 128 × 128 pixels; slice thickness 10
mm; GRAPPA rate 2; voxel size 2.5 × 2.5 mm, temporal
resolution 123ms, 8 frames/s). The only sequence param-
eter modified by the scan operator was the field of view
when required according to patient habitus.
Two different types of CE-marked 0.035″ diameter
CMR conditional guidewires were available during the
study period, namely the Emery Glide Straight tip MR
Wire (Nano4Imaging GmbH, Aachen, Germany) and
the MRline guidewire (EPflex Feinwertechnik GmbH,
Dettingen an der Erms, Germany). The choice of guide-
wire was determined by product availability (in five
cases) and operator discretion (in one case). The prox-
imal portion of both guidewires were equipped with
CMR visible markers allowing visualization as additional
image artefacts around the passive markers.
CMR hemodynamic assessment
Once in the wedge position, both pulmonary capillary
wedge pressure (PCWP) and mean pulmonary artery
pressure (mPAP) were measured. Flow data in the prox-
imal ascending aorta, sub-pulmonary artery and right
Fig. 1 Cardiovascular magnetic resonance-right heart catheterization
(CMR-RHC) procedure room equipment set-up. a 1.5 T CMR scanner
with one large sterile drape attached to the front and side of the
scanner, and one small sterile drape attached to the front of the
scanner and passing into the bore. b CMR compatible drip stand
with pressure transducer. c CMR-compatible monitor to mirror the
scanner display for in-room catheter visualization. d CMR-compatible
blood pressure monitor (displaying invasive and non-invasive blood
pressure measurements along with pulse oximetry)
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and left branch PA were acquired using a conventional free
breathing velocity-encoded phase contrast sequence to de-
rive cardiac output. This allowed calculation of PVR using
the formula: PVR = (mPAP – PCWP) / cardiac output. A
cine stack of short-axis slices for assessment of biventricular
volumes along with a 4-chamber cine were then acquired.
Cine imaging was performed using a breath-hold balanced
steady-state free precession (bSSFP) sequence unless the
patient had difficulty with breath-holding, at which point
real-time cine imaging was utilized. All CMR imaging was
performed using commercially available sequences. Tricus-
pid and pulmonary regurgitant fractions were calculated as
described previously [1].
The full workflow for a CMR-RHC study is shown in
Fig. 4, with four specific timed components of the study
defined as follows:
 Catheter time represented the time taken from
catheter insertion at the venous sheath to obtaining
a stable pulmonary capillary wedge position. This
includes catheter manipulation under real-time
CMR-guidance and pressure recordings. Sampling of
PA blood for measurement of oxygen saturations
was performed as it has been shown to be
prognostic independent of cardiac index [9] and is
part of our standard PAH data set. In addition,
Fig. 2 Three reference views acquired using the interactive real-time sequence. a Bicaval view, b Right ventricular long axis (RVLA) view, c Main
pulmonary artery (PA) bifurcation view
Fig. 3 The air-filled balloon of the balloon wedge-pressure end-hole catheter visualized as a signal void passing through the right heart,
pulmonary artery and finally to the wedge position under CMR visualization. Here, the balloon is seen in the a right atrium, b right ventricle, c
right ventricular outflow tract, d main pulmonary artery, e right branch pulmonary artery approaching a wedge position, f wedge position
Knight et al. Journal of Cardiovascular Magnetic Resonance           (2019) 21:57 Page 4 of 11
oximetry was performed to confirm satisfactory
wedge position in cases where the PCWP was ≥13
mmHg.
 Catheter and flows time included the catheter time
plus the acquisition of phase contrast CMR data for
proximal ascending aorta, sub-pulmonary artery and
right and left branch PA flows.
 Study time was defined as the total time required for
acquiring a complete CMR-RHC study dataset,
including the time taken to acquire all cine imaging
in addition to the catheter and flows time.
 Department time comprised the total time the
patient spent in the CMR department, including all
procedural preparation, acquisition of scout and
localizer images, study time, extraction from the
scanner and transfer out of the department to the
recovery ward.
Statistics
All statistical analyses were performed in R (Rstudio 1.14).
Data were examined for normality using the Shapiro Wilk
test. Normally distributed variables were expressed as
mean ± standard deviation. Non-normally distributed vari-
ables were expressed as median (interquartile range). Pro-
portions were expressed as percentages.
Procedural failure and guidewire usage were combined
as an outcome variable due to significant overlap. Asso-
ciations between this outcome and hemodynamic and
CMR measures were assessed using logistic regression.
Spearman’s correlation coefficient was used to analyse
the relationships between catheter time and hemodynamic
and CMR measures, as well as all timing parameters and




Patient demographics are summarized in Table 1. The
majority of the patient cohort (32, 64%) were in World
Health Organisation (WHO) functional class III. The
significant female preponderance of patients (80%) is re-
flective of the underlying disease processes in our co-
hort; 30 out of 40 female patients (75%) had connective
tissue disease and seven (18%) had idiopathic PH.
Fig. 4 Workflow for a CMR-RHC study with four specific timed components of the study. Catheter time, catheter plus flows time, full CMR-RHC
study time and the department time were all recorded
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Twenty-six (52%) patients already had a known diag-
nosis of PH, the majority of whom (25, 96%) were
already on pulmonary vasodilator therapy. This included
2 patients who were receiving continuous intravenous
epoprostenol. Twenty-four patients had suspected PH
and the CMR-RHC was their index invasive
hemodynamic assessment. In this group, 13 patients had
the diagnosis confirmed and 11 patients (10 with sclero-
derma and 1 with antisynthetase syndrome) had normal
PA pressures. Invasive and CMR derived measures are
shown in Table 2, demonstrating a wide spectrum of
pulmonary hemodynamics and right heart sizes amongst
the patient population.
Procedural details and success
Forty-nine CMR-RHC studies were performed using
femoral venous access and one study (patient number
16) was performed from the right internal jugular vein
due to the presence of an inferior vena cava filter. The
femoral vein was successfully identified and cannulated
by manual palpation in 48 patients and using ultrasound
guidance in 1 case; ultrasound guidance was used as the
default technique for internal jugular venous access.
There were no significant vascular complications, with a
simple hematoma reported in one patient that was con-
servatively managed. Sedation was offered to all patients
and subsequently used in 17 (34%) patients without
complication; the remaining 33 (66%) of patients de-
clined any sedation as per their preference. No patients
requested the study to be terminated early.
A full CMR-RHC study was successfully completed in
47 (94%) patients and failed in 3 (6%) patients (patients
7, 47 and 50). In 2 cases (patients 7 and 47) the catheter
could not be advanced from the RV to PA and in the
other case (patient 50) the catheter could not be
Table 1 Patient demographics
Characteristic Finding Range (min-max)
Age (years) 57 +/− 15 20–83
Female gender, n (%) 40 (80)
Height (m) 1.63 (1.56–
1.73)
1.46–1.95
Weight (kg) 71 +/− 16 40–105
BSA (m2) 1.8 +/− 0.2 1.4–2.4
6MWD (metres) 333 (150–440) 0–582
NT-proBNP (ng/L) 320 (110–841) 50–52,746





PAH, n (%) 39 (78)





Group 2 2 (4)
Group 3 2 (4)
Group 4 1 (2)
Group 5 1 (2)
PAH therapy, n (%)
- Phosphodiesterase type 5
inhibitor
24 (48)
- Endothelin receptor antagonist 23 (46)
- Intravenous Epoprostenol 2 (4)
All normally distributed data are presented as mean ± standard deviation, non-
parametric data are presented as median (Q1-Q3) and proportions as n (%)
BSA Body surface area, CTD Connective tissue disease, NT-proBNP N-terminal
pro-brain natriuretic peptide, PAH Pulmonary artery hypertension, PVOD
Pulmonary veno-occlusive disease, WHO FC World Health Organisation
Functional Class, 6MWD 6-min walk distance
Table 2 Right heart catheterization and CMR data or range
Variable Finding Range (min-max)
RVSP (mmHg) 59 (40–78) 24–132
RVDP (mmHg) 8 (6–12) 1–25
mPAP (mmHg) 35 +/− 14 12–80
PCWP (mmHg) 9 (8–11) 4–35
TPG (mmHg) 25 (13–35) 6–72
CO (L/min) 5.1 +/− 1.4 3.0–9.4
PVR (dynes.sec.cm− 5) 400 (197–615) 80–1340
RVEDV (mL) 135 +/− 37 51–243
RVESV (mL) 58 (43–75) 14–159
RVSV (mL) 70 +/− 19 36–121
RVEF (%) 54 +/− 13 20–76
RV mass (g) 69 +/− 28 20–142
RA area (cm2) 23 +/− 6 11–42
LVEDV (mL) 103 (82–131) 54–278
LVESV (mL) 36 (28–50) 15–203
LVSV (mL) 71 +/− 21 35–116
LVEF (%) 65 (60–71) 27–83
LV mass (g) 108 (88–135) 64–258
LA area (cm2) 22 +/− 6 10–36
All normally distributed data are presented as mean ± standard deviation, non-
parametric data are presented as median (Q1-Q3)
CO Cardiac output, EDV End diastolic volume, EF Ejection fraction, ESV End
systolic volume, LA Left atrium, LV Left ventricle, LVEDV left ventricular end-
diastolic volume, LVEF left ventricular ejection fraction, LVESV left ventricular
end-systolic volume, LVSV left ventricular stroke volume, mPAP Mean
pulmonary artery pressure, PCWP Pulmonary capillary wedge pressure, PVR
Pulmonary vascular resistance, RA Right atrium, RV Right ventricle, RVDP Right
ventricular diastolic pressure, RVEDV right ventricular end-diastolic volume,
RVESV right ventricular end-systolic volume, RVSP Right ventricular systolic
pressure, SV Stroke volume, TPG Transpulmonary gradient
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advanced from the right atrium (RA) to a stable RV pos-
ition. All three procedural failures used the femoral ven-
ous approach. These patients subsequently underwent
conventional X-ray fluoroscopic guided RHC on the same
day, with patients 7 and 47 requiring a loop to be formed
in the RA and patients 47 and 50 also necessitating the
use of a Nitinol guidewire. CMR-conditional guidewires
(Nano4Imaging = 1, EPFlex = 5) were used in six patients
without complication. In two of these patients, the pro-
cedure ultimately failed and in the other four it succeeded.
Real-time cine imaging was required in a total of nine
(19%) patients due to difficulties in breath-holding cine
acquisition, only one of whom had received intravenous
sedation. In addition, four patients (8%; cases 6, 15, 17 and
23) had additional clinically indicated tissue characterisa-
tion assessments performed, one of whom (subject #6)
included late gadolinium enhancement imaging and extra-
cellular volume quantification at 15-min post-contrast ad-
ministration. The only two catheter-related adverse events
comprised asymptomatic hypotension in two patients
(cases 3 and 47) that corrected immediately with intraven-
ous crystalloid whilst in the scanner bore.
Metrics that were significantly associated with
guidewire use or procedural failure were those that
reflected the severity of PAH, right heart dilatation,
RV hypertrophy and RV dysfunction (Table 3). All
three patients in whom CMR-RHC was unsuccessful
were in WHO functional class IV and had severe pre-
capillary PAH with significantly dilated and impaired
right hearts (Table 4). The composite endpoint of
procedural failure or guidewire use was not associated
with procedure number, cardiac output or tricuspid
or pulmonary regurgitant fraction.
Procedural duration
Procedural timings are summarized in Table 5, with a
median catheter time of 3.6 (2.0–7.7) minutes (range
0.6–15.1). The mean time to complete the full CMR-
RHC protocol (including catheter advancement, great
vessel flow assessment and biventricular cine stack) was
31.7 ± 7.8 min (range 19.0–49.8). The median total de-
partment time (CMR-RHC plus patient preparation and
transfer time) was 60.0 (range 54.0–68.5) minutes (range
45.0–92.0), respectively. There were no significant differ-
ences in any of the four timed components of the study
with or without sedation use.
Times plotted against procedure number are shown in
Fig. 5, with all times becoming significantly shorter with
increasing procedural experience (p < 0.05). However, it
can be seen that total department time fell more quickly
than catheter time or total procedure time. Severe PH,
right heart dilatation, RV hypertrophy and RV dysfunc-
tion were all associated with longer catheter times
(Table 6). Catheter time was not associated with cardiac
output or tricuspid or pulmonary regurgitant fraction.
Table 3 Time data
Variable (minutes) Finding Range (min-max)
Catheter time (min) 3.6 (2.0–7.7) 0.6–15.1
Catheter and flows time (min) 15.0 (10.9–17.8) 8.0–28.1
Study time (min) 31.7 +/− 7.8 19.0–49.8
Department time (min) 60.0 (54.0–68.5) 45.0–92.0
All normally distributed data are presented as mean ± standard deviation, non-
parametric data are presented as median (Q1-Q3)
Table 4 Association with guidewire use and procedural failure
Variable OR P
RVESV 1.028 (1.005–1.053) 0.018*
RVEDV 1.019 (0.997–1.042) 0.089
RVSV 0.973 (0.928–1.019) 0.24
RVEF 0.914 (0.852–0.982) 0.014*
RV mass 1.050 (1.014–1.088) 0.0067†
RA area 1.178 (1.020–1.361) 0.026*
Tricuspid RF 1.056 (0.984–1.133) 0.132
Pulmonary RF 1.146 (0.967–1.357) 0.116
RVSP 1.075 (1.014–1.139) 0.015*
mPAP 1.125 (1.020–1.240) 0.018*
TPG 1.111 (1.021–1.209) 0.014*
CO 0.614 (0.303–1.245) 0.18
PVR 1.005 (1.001–1.009) 0.0061†
CO Cardiac output, EDV End diastolic volume, EF Ejection fraction, ESV End
systolic volume, mPAP Mean pulmonary artery pressure, OR Odds ratio, PVR
Pulmonary vascular resistance, RA Right atrium, RF Regurgitant fraction, RV
Right ventricle, RVEDV right ventricular end-diastolic volume, RVEF right
ventricular ejection fraction, RVESV right ventricular end-systolic volume, RVSP
Right ventricular systolic pressure, SV Stroke volume, TPG
Transpulmonary gradient
*P < 0.05, †P < 0.01
Table 5 Characteristics of patients who had procedural failure
Variable Case 7 Case 47 Case 50
WHO FC 4 4 4
RVEDV (mL) 200 193 146
RVESV (mL) 159 141 87
RVEF (%) 20 27 40
RV mass (g) 142 123 87
RA area (cm2) 33 25 31
RVSP (mmHg) 65 82 92
mPAP (mmHg) 58 50 52
EDV End diastolic volume, EF Ejection fraction, ESV End systolic volume, mPAP
Mean pulmonary artery pressure, RA Right atrium, RV Right ventricle, RVSP
Right ventricular systolic pressure, WHO FC World Health Organisation
Functional Class
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Discussion
The main findings of this study were: 1) CMR-RHC is
feasible within a normal clinical workflow with standard
technology in an adult population of patients with sus-
pected or known PAH, 2) Procedural failure is rare, but
more likely in patients with severe disease (both in terms
of PA pressure and right heart chamber dilatation), 3)
Procedure time increases with worsening disease but is
still in the clinically acceptable range. Overall, this study
demonstrates that CMR-RHC can be safely performed in
patients with adverse cardiopulmonary hemodynamics
and incorporated into routine clinical practice without
the need for expensive extra infrastructure. We have
shown that CMR-RHC has comparable procedure times
to a standard CMR examination but with the additional
hemodynamic information provided by invasive right
heart catheterization, all in a single procedure.
CMR-guided RHC is not a new concept [4–6] with re-
cent work demonstrating the feasibility of the technique
in large groups of patients [7]. Furthermore, measure-
ment of cardiac output using phase contrast CMR has
previously been validated against the Fick principle, fa-
cilitating a robust method to assess PVR by CMR-RHC
[6, 7]. However, previous studies have not focused on
Fig. 5 Procedure times plotted against procedure number. All times became significantly shorter with increasing procedural experience (p < 0.05).
Department times were unavailable for the first two cases as this component of the procedural workflow was not originally part of the study
protocol. As such, department times were only recorded after the first two cases had taken place






RV mass 0.43 0.0025†
RA area 0.38 0.0090†
Tricuspid RF −0.023 0.88






CO Cardiac output, EDV End diastolic volume, EF Ejection fraction, ESV End
systolic volume, mPAP Mean pulmonary artery pressure, PVR Pulmonary
vascular resistance, RA Right atrium, RF Regurgitant fraction, RV Right
ventricle, RVEDV right ventricular end-diastolic volume, RVEF right ventricular
ejection fraction, RVESV right ventricular end-systolic volume, RVSP Right
ventricular systolic pressure, SV Stroke volume, TPG Transpulmonary gradient
*P < 0.05, †P < 0.01
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CMR-RHC in acquired PAH, particularly patients with
more severe disease. This is the first study of CMR-
RHC in a large group of patients attending for the
evaluation of suspected or known PAH. The majority
of our patients were in WHO functional class 3 and
are representative of the overall clinical population
referred for RHC at a large adult PAH center. The
technique was feasible in the majority of patients,
suggesting that it has a role as a routine clinical inves-
tigation in this setting.
Procedural failure and guidewire usage
Only three out of 50 RHC cases were unsuccessful in
the CMR environment, although in six instances a
guidewire was used with two of these still ending in fail-
ure. Due to the significant overlap between guidewire
usage and failure, we used a composite outcome of
guidewire use or failure to investigate hemodynamic and
CMR associations. The main measures associated with
guidewire use or failure were higher PA pressures and
increasing RV dilation, hypertrophy and dysfunction. In
fact, all three patients in whom the procedure failed had
significantly deranged pulmonary hemodynamics and se-
verely hypertrophied, dilated and impaired right hearts.
The relationship between right heart size and failure or
guidewire use is unsurprising as catheter manipulation
does become more difficult in dilated chambers, particu-
larly if systolic function is reduced. We also found that
the catheter can become lodged in the thickened trabe-
culations of the hypertrophied RV, explaining the associ-
ation with RV mass. It is likely that higher PA pressures
associated with guidewire use or failure are a surrogate
for right heart chamber dilatation, rather than represent-
ing a direct effect on catheter manipulation.
In the conventional cardiac catheterization laboratory,
these obstacles are overcome by using a metallic guide-
wire, creating catheter loops in the RA and/or by using
internal jugular venous access. We did have access to
CMR-conditional guidewires, with a successful outcome
in four cases. However, these devices lack the mechan-
ical properties of their metallic equivalents and currently
only have discrete markers towards the guidewire tip for
visualization. This is in comparison to metallic guide-
wires that can be visualized along their whole length
using X-ray fluoroscopy. Furthermore, only the catheter
balloon is visible in CMR whilst the catheter shaft is not
seen. We believe that these combined limitations in
guidewire and catheter shaft visualization preclude the
safe formation of catheter loops using CMR in a conven-
tional CMR scanner environment in which immediate
X-ray fluoroscopic back-up is unavailable. Improvements
in guidewire technology may overcome these limitations,
and recent work has also focused on improving catheter
shaft visibility using nitinol-based guidewires in the
CMR environment under low-specific absorption rate
(SAR) CMR protocols [10]. Overall, our early experience
suggests that procedural failure using femoral venous
access is uncommon even using standard equipment
and was confined to WHO functional class 4 patients
with PH. Alternative approaches could be considered
for this group of patients attending for CMR-RHC,
including the use of different CMR-safe catheters (pre-
shaped balloon-tipped or non-balloon-tipped, with or
without CMR-conditional guidewires) and internal
jugular venous access.
Procedure time
One of the main arguments against CMR-RHC has been
long procedure times. However, we demonstrate that
catheterization and total procedure times were relatively
short. Each patient only occupied the department for
approximately 1 hour, allowing 3–4 cases to be per-
formed in a single half-day session. Furthermore,
CMR-RHC not only provides measures of PA pres-
sure and PVR, but also of biventricular size and func-
tion. Therefore, we believe that CMR-RHC is a
feasible and time efficient method of physiologically
assessing patients with PH. The catheter time mod-
estly improved with procedure number, reflecting a
learning curve with advancing a catheter under CMR-
guidance. However, total procedure and department
times fell by an even greater amount with increasing
procedural experience. This suggests that the main
improvements come from improved workflow rather
than faster catheterization. Study times could be fur-
ther improved with the use of accelerated imaging for
the acquisition of great vessel flows and cine images.
However, the aim of this study was to demonstrate
the feasibility of CMR-RHC using standard commer-
cially available hardware and software in order to dis-
seminate the technique without the need for non-
standard equipment and sequences.
To our knowledge, this is the first study to investi-
gate the association between catheterization time and
hemodynamic parameters. As with procedure failure,
the main associations were higher PA pressures and
increasing RV dilation, hypertrophy and dysfunction.
The reasons for these associations are similar to pre-
viously described for failure and guidewire usage. This
suggests that it might be useful to ensure a mix of
disease severity when performing multiple cases in
the same session.
Combining hemodynamic and CMR data provides
a comprehensive assessment of patients under inves-
tigation for PAH in a single study. However, these
data can routinely be obtained at separate appoint-
ments. Our CMR-RHC procedure times are faster
than the total duration of the component
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investigations performed individually. This confers
potential advantages that include cost savings and
faster clinical workflows, benefitting both patients
and the institution. The times reported in this study
included the learning curve that is inherent in set-
ting up a clinical CMR-RHC service. Analyses of the
impact of an established CMR-RHC program on cost
and patient experience would be worthwhile in
evaluating the clinical utility of this combined ap-
proach in a tertiary PAH referral center.
Limitations
Patients routinely had CMR-RHC performed via the
femoral approach as per our standard institution proto-
col. However, the buoyancy and natural upward-pointing
arc of the air-filled balloon catheter via the internal
jugular venous approach could be advantageous in more
technically challenging cases, and merits further study.
Furthermore, the use of alternative commercially avail-
able CMR-safe curved-tip catheters may have offered
greater potential for procedural success in these cases
[7]. Whilst the air-filled balloon was adequately visual-
ized in our cohort of patients, previous studies have
shown that gadolinium-filled balloons were more con-
sistently conspicuous especially when using a saturation-
preparation sequence [4]. Air-filled balloons have the
advantages of greater buoyancy and more favourable
inflation characteristics, but the enhanced visibility of
gadolinium-filled balloons may be advantageous in cases
of more complex anatomy that were not encountered in
our cohort. Similarly, dedicated interventional CMR
workstations that offer simultaneous real-time
visualization of multiple scan planes may be beneficial in
such complex cases. Our set-up utilized the scanner
headphones to communicate between catheter and
scanner operators, with the patient receiving regular
verbal checks by nursing staff and also holding the
emergency alarm to signal if they needed to commu-
nicate. This approach worked well for our short
CMR-RHC studies, but commercially available sys-
tems that enable communication amongst circulating
staff and with patients in the CMR environment
provide an alternative solution [4, 7]. These systems
may be of particular use in complex interventional
CMR, but at an additional cost to purchase. We did
not record equivalent time parameters for patients
undergoing RHC under X-ray-fluoroscopic guidance
as a comparator group. However, our CMR-RHC
procedure times are nevertheless of a similar order of
magnitude to a conventional cardiac catheterization
laboratory. Our patient cohort was also not large
enough to perform multivariable analysis of the pre-
dictors of guidewire usage and procedural failure.
However, the factors identified in this study are likely
related to one another, and, as such, provide a signal
as to the scenarios in which CMR-RHC may be more
challenging.
Conclusions
CMR-guided RHC is a safe and feasible technique
for the investigation of PAH that can be performed
within a normal clinical CMR environment. Our ap-
proach using standard CMR technology is widely
applicable and generalizable, allowing dissemination
of the technique to other PAH centres. The favor-
able CMR-RHC procedure times allow a more com-
prehensive patient assessment to be performed
within the timeframe of a routine clinical CMR
workflow, conferring potential financial savings and
improvements in clinical productivity. Using CMR
for the simultaneous measurement of pulmonary
pressures and cardiac volumes also has great poten-
tial for advancing our understanding of PAH, pro-
viding a platform to investigate potential novel
biomarkers that reflect the simultaneous assessment
of the right heart and pulmonary circulation.
Additional files
Additional file 1: Video S1 Patient preparation. The patient lays on the
scanner table to have surface vector-cardiogram electrodes attached and
a phased array body coil positioned. The scanner table is then undocked
and transferred to the preparation area outside the scanner room. Video
S2 Vascular access. The venous sheath is inserted under local anaesthetic
using either manual palpation or under ultrasound guidance. The patient
is connected to an electrocardiogram (ECG) monitor and a blood
pressure monitor during the sheath insertion to monitor for vasovagal
events. Video S3 Drape wrap. The sterile drape is folded over onto the
patient firstly from the operator side and subsequently from the opposite
side of the table (the latter fold using the underside of the drape) in
order to maintain sterility of the operating field. Video S4 Transfer to
scanner. The patient is transferred back into the CMR scanner room. At
the same time as vascular access is obtained, the side of the scanner
and the inner curvature of the bore on the side of the operator (the
side of venous access) are draped. A CMR-compatible non-invasive
blood pressure cuff and a peripheral oxygen saturation finger probe
are attached to the patient prior to being positioned inside the
scanner bore. (MOV 18383 kb)
Additional file 2: Video S5 Interactive real-time CMR-guidance of the
air-filled balloon of the balloon wedge-pressure end-hole catheter. This is
visualized as a signal void passing through the right heart, pulmonary
artery and finally to the wedge position. The interactive real-time
sequence allows the catheter to be ‘tracked’ by switching between the
previously stored reference views with real-time adjustments. (MOV
11903 kb)
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